NCT00675831View on ClinicalTrials.gov

Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Hematologic Malignancies

Interventions

DEVICE

CliniMACS CD25 Reagent Device

Used to engineer CD25+ depleted donor lymphocytes which will be infused intravenously over 5-10 minutes

Trial Locations (1)

02115

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Miltenyi Biomedicine GmbH

All Listed Sponsors

collaborator

Miltenyi Biomedicine GmbH

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER